Bessemer Group’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$152M Sell
288,814
-30,451
-10% -$17.1M 0.21% 125
2026
Q1
$179M Buy
319,265
+7,916
+3% +$5.08M 0.28% 84
2025
Q4
$211M Sell
311,349
-40,919
-12% -$27.9M 0.32% 73
2025
Q3
$225M Sell
352,268
-29,560
-8% -$17.9M 0.34% 76
2025
Q2
$205M Buy
381,828
+41,766
+12% +$20M 0.33% 76
2025
Q1
$143M Buy
340,062
+110,816
+48% +$48.1M 0.26% 103
2024
Q4
$94.8M Buy
229,246
+216,572
+1,709% +$95M 0.15% 144
2024
Q3
$6.4M Buy
12,674
+29
+0.2% +$14.1K 0.01% 377
2024
Q2
$6.16M Sell
12,645
-530
-4% -$266K 0.01% 346
2024
Q1
$7.11M Sell
13,175
-2,441
-16% -$1.33M 0.01% 343
2023
Q4
$8.67M Sell
15,616
-454
-3% -$213K 0.02% 312
2023
Q3
$7.03M Buy
16,070
+879
+6% +$438K 0.02% 312
2023
Q2
$7.63M Buy
15,191
+528
+4% +$253K 0.02% 295
2023
Q1
$7.33M Sell
14,663
-151
-1% -$72.3K 0.02% 286
2022
Q4
$6.04M Sell
14,814
-70
-0.5% -$27.2K 0.01% 308
2022
Q3
$4.85M Sell
14,884
-230
-2% -$84.5K 0.01% 324
2022
Q2
$5.3M Buy
15,114
+1,242
+9% +$506K 0.01% 298
2022
Q1
$7.59M Buy
13,872
+821
+6% +$432K 0.02% 231
2021
Q4
$8.59M Buy
13,051
+1,009
+8% +$633K 0.02% 216
2021
Q3
$7.49M Buy
12,042
+12
+0.1% +$8.06K 0.02% 230
2021
Q2
$7.6M Buy
12,030
+28
+0.2% +$15.5K 0.02% 235
2021
Q1
$5.87M Sell
12,002
-285
-2% -$143K 0.01% 250
2020
Q4
$6.14M Buy
12,287
+55
+0.4% +$24.6K 0.02% 238
2020
Q3
$4.81M Sell
12,232
-2,672
-18% -$988K 0.01% 250
2020
Q2
$4.92M Buy
14,904
+3,879
+35% +$1.12M 0.02% 293
2020
Q1
$2.67M Buy
11,025
+542
+5% +$141K 0.01% 382
2019
Q4
$2.74M Buy
10,483
+17
+0.2% +$4.48K 0.01% 481
2019
Q3
$2.85M Hold
10,466
0.01% 419
2019
Q2
$2.88M Buy
10,466
+236
+2% +$58.1K 0.01% 433
2019
Q1
$2.29M Sell
10,230
-58
-0.6% -$12K 0.01% 420
2018
Q4
$1.91M Buy
10,288
+100
+1% +$20.5K 0.01% 392
2018
Q3
$2.54M Buy
10,188
+90
+0.9% +$21.8K 0.01% 340
2018
Q2
$2.2M Sell
10,098
-1,884
-16% -$388K 0.01% 386
2018
Q1
$2.29M Buy
11,982
+437
+4% +$80.7K 0.01% 377
2017
Q4
$1.8M Sell
11,545
-69
-0.6% -$10.9K 0.01% 446
2017
Q3
$1.81M Sell
11,614
-68
-0.6% -$10.8K 0.01% 469
2017
Q2
$1.89M Sell
11,682
-1,751
-13% -$284K 0.01% 486
2017
Q1
$2.08M Sell
13,433
-4,482
-25% -$618K 0.01% 495
2016
Q4
$2.1M Sell
17,915
-374
-2% -$42.7K 0.01% 508
2016
Q3
$2.06M Sell
18,289
-2,988
-14% -$315K 0.01% 438
2016
Q2
$1.98M Sell
21,277
-3,124
-13% -$268K 0.01% 386
2016
Q1
$1.91M Sell
24,401
-8,459
-26% -$609K 0.01% 392
2015
Q4
$2.4M Sell
32,860
-35
-0.1% -$2.5K 0.01% 393
2015
Q3
$2.44M Sell
32,895
-8,417
-20% -$603K 0.01% 372
2015
Q2
$2.65M Buy
41,312
+7,652
+23% +$530K 0.01% 354
2015
Q1
$2.6M Hold
33,660
0.01% 341
2014
Q4
$2.5M Buy
33,660
+2,128
+7% +$149K 0.01% 331
2014
Q3
$1.86M Buy
31,532
+21,400
+211% +$1.35M 0.01% 383
2014
Q2
$677K Buy
10,132
+10,032
+10,032% +$638K ﹤0.01% 518
2014
Q1
$6K Hold
100
﹤0.01% 1147
2013
Q4
$5K Hold
100
﹤0.01% 1178
2013
Q3
$5K Hold
100
﹤0.01% 1113
2013
Q2
$4K Buy
+100
New +$4.37K ﹤0.01% 1173

Other funds holding IDXX

Bessemer Group's IDXX Position: Q2 2026 in Review

Bessemer Group reduced its Idexx Laboratories (IDXX) stake by 9.5% in Q2 2026, selling an estimated $17.1M and leaving 288,814 shares worth $152M. The position accounts for 0.21% of the portfolio, ranked #125.

Bessemer Group first reported a position in IDXX in Q2 2013 and has held it in 53 quarters since. The position peaked at $225M in Q3 2025. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Bessemer Group held 288,814 shares of Idexx Laboratories worth $152M as of Q2 2026.
  • Bessemer Group sold 30,451 Idexx Laboratories shares in Q2 2026, an estimated $17.1M.
  • Idexx Laboratories made up 0.21% of Bessemer Group's portfolio in Q2 2026, its #125 holding.
  • Bessemer Group first reported a position in Idexx Laboratories in Q2 2013 and has held it in 53 quarters since.
  • Bessemer Group's Idexx Laboratories position peaked at $225M in Q3 2025.
  • 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Bessemer Group's 13F filing for Q2 2026, filed 12 Aug 2026.